No black box warning on record for Targretin

As of the latest FDA labeling reviewed, Targretin (BEXAROTENE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Targretin medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Hyperlipidemia: TARGRETIN causes elevations in blood lipids. Obtain baseline values, monitor, and manage elevations during therapy by dose reduction, interruption, discontinuation and/or lipid lowering therapy. ( 5.1 , 5.11 ) • Pancreatitis: Interrupt TARGRETIN and evaluate if suspected. ( 5.2 ) • Hepatotoxicity, Cholestasis, and Hepatic Failure: Interrupt or discontin

No black box warning on record for Targretin

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Hyperlipidemia: TARGRETIN causes elevations in blood lipids. Obtain baseline values, monitor, and manage elevations during therapy by dose reduction, interruption, discontinuation and/or lipid lowering therapy. ( 5.1 , 5.11 ) • Pancreatitis: Interrupt TARGRETIN and evaluate if suspected. ( 5.2 ) • Hepatotoxicity, Cholestasis, and Hepatic Failure: Interrupt or discontin

Targretin Black Box Warning

No black box warning on record for Targretin

Other warnings & precautions

Targretin Black Box Warning

No black box warning on record for Targretin

Other warnings & precautions